SCHEMBL10144479

SCHEMBL10144479

CC(C)(C)CC(=O)C1CN(CCN)CCN1C(=O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
TMEM97 Q5BJF2 3/20 0.42
SIGMAR1 Q99720 3/20 0.42
PREP P48147 3/20 0.42
NPSR1 Q6W5P4 2/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
THPO P40225 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13227748 0.86 PDK1 (0.46) PDK1PDK2PDK3PDK4TMEM97
SCHEMBL10144609 0.81 SIGMAR1 (0.44) PDK1PDK2PDK3PDK4TMEM97
SCHEMBL3783660 0.79 KLK7 (0.47) TMEM97SIGMAR1PREPNPSR1TSHR
SCHEMBL13227761 0.74 TMEM97 (0.49) PDK1PDK2PDK3PDK4TMEM97
SCHEMBL29300887 0.73 PDK1 (0.59) PDK1PDK2PDK3PDK4TMEM97
SCHEMBL13260930 0.73 DRD2 (0.48) PDK1PDK2PDK3PDK4SIGMAR1
SCHEMBL11256972 0.72 SMN1; SMN2 (0.49) PREPNPSR1CYP2C19SMN1; SMN2
SCHEMBL335166 0.72 MEN1 (0.59) TMEM97SIGMAR1NPSR1CYP2C19SMN1; SMN2
SCHEMBL18851102 0.72 DRD2 (0.49) PDK1PDK2PDK3PDK4SIGMAR1
SCHEMBL13227741 0.72 SIGMAR1 (0.53) PDK1PDK2PDK3PDK4TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079743-B1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD (GB) 2012-01-25 EP disclosed